July 18th 2011
Dr. Brian Rini from Taussig Cancer Institute on the Progression of Advanced RCC Therapy
July 14th 2011
Dr. Brian I. Rini from the Cleveland Clinic on Standards of Care for Advanced RCC
July 11th 2011
Dr. Brian I. Rini from the Taussig Cancer Institute Explains the Axitinib Integration Process
July 6th 2011
Dr. Brian I. Rini from the Taussig Cancer Institute Describes Axitinib's and Sorafenib's Side Effects
July 1st 2011
Dr. Brian Rini from Taussig Cancer Institute explains the Axitinib and Sorafenib AXIS Trial VEGF Potency Focus
June 27th 2011
Dr. Brian Rini from the Cleveland Clinic Taussig Cancer Institute on the Axitinib and Sorafenib Trial Hazard Ratio
June 24th 2011
Dr. Brian Rini from the Cleveland Clinic Taussig Cancer Institute on the Results From His Axitinib and Sorafenib Trial